138 related articles for article (PubMed ID: 33277858)
1. GATA6 activated long non-coding RNA PCAT1 maintains stemness of non-small cell lung cancer by mediating FRK.
Zang Q; Xu L; Li J; Jia H
J BUON; 2020; 25(5):2371-2381. PubMed ID: 33277858
[TBL] [Abstract][Full Text] [Related]
2. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
Xiao XH; He SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
[TBL] [Abstract][Full Text] [Related]
3. LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non-small cell lung cancer.
Gao Y; Zhang N; Zeng Z; Wu Q; Jiang X; Li S; Sun W; Zhang J; Li Y; Li J; He F; Huang Z; Zhang J; Gong Y; Xie C
Clin Transl Med; 2022 Apr; 12(4):e792. PubMed ID: 35415876
[TBL] [Abstract][Full Text] [Related]
4. LncRNA PCAT1 Interacts with DKC1 to Regulate Proliferation, Invasion and Apoptosis in NSCLC Cells via the VEGF/AKT/Bcl2/Caspase9 Pathway.
Liu SY; Zhao ZY; Qiao Z; Li SM; Zhang WN
Cell Transplant; 2021; 30():963689720986071. PubMed ID: 33461333
[TBL] [Abstract][Full Text] [Related]
5. FRK plays an oncogenic role in non-small cell lung cancer by enhancing the stemness phenotype via induction of metabolic reprogramming.
Zhang L; Yang Y; Chai L; Bu H; Yang Y; Huang H; Ran J; Zhu Y; Li L; Chen F; Li W
Int J Cancer; 2020 Jan; 146(1):208-222. PubMed ID: 31251822
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA SOX2OT maintains the stemness of pancreatic cancer cells by regulating DEK via interacting with miR-200a/141.
Liu CS; Zhou Q; Zhang YD; Fu Y
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2368-2379. PubMed ID: 32196588
[TBL] [Abstract][Full Text] [Related]
8. IRF-1 mediated long non-coding RNA PVT1-214 promotes oxaliplatin resistance of colorectal cancer via miR-128 inhibition.
Tong D; Zou E; Bai L; Ma J; Guo N; Wang H; Jiang L
J BUON; 2020; 25(5):2205-2214. PubMed ID: 33277837
[TBL] [Abstract][Full Text] [Related]
9. LncRNA LINC00680 promotes lung adenocarcinoma growth via binding to GATA6 and canceling GATA6-mediated suppression of SOX12 expression.
Sun X; Wang R; Tan M; Tian X; Meng J
Exp Cell Res; 2021 Aug; 405(1):112653. PubMed ID: 34029572
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
Hao XZ; Yang K
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA HOTAIR regulates the development of non-small cell lung cancer through miR-217/DACH1 signaling pathway.
Chen SS; Peng M; Zhou GZ; Pu YC; Yi MC; Zhu Y; Jiang B
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):670-678. PubMed ID: 30720199
[TBL] [Abstract][Full Text] [Related]
13. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
Yang J; Du YM; Li B
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA FAM201A involves in radioresistance of non-small-cell lung cancer by enhancing EGFR expression via miR-370.
Liu AM; Zhu Y; Huang ZW; Lei L; Fu SZ; Chen Y
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5802-5814. PubMed ID: 31298332
[TBL] [Abstract][Full Text] [Related]
15. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
[TBL] [Abstract][Full Text] [Related]
16. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R
J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
Jing H; Xia H; Qian M; Lv X
Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
[TBL] [Abstract][Full Text] [Related]
19. LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes.
Yang W; Qian Y; Gao K; Zheng W; Wu G; He Q; Chen Q; Song Y; Wang L; Wang Y; Gu P; Chen B; Zhai R
Carcinogenesis; 2021 Feb; 42(1):80-92. PubMed ID: 32459848
[TBL] [Abstract][Full Text] [Related]
20. GATA6-upregulating autophagy promotes TKI resistance in nonsmall cell lung cancer.
Ma R; Li X; Liu H; Jiang R; Yang M; Zhang M; Wang Y; Zhao Y; Li H
Cancer Biol Ther; 2019; 20(9):1206-1212. PubMed ID: 31092103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
